Article Image
IPFS News Link • Vaccines and Vaccinations

Second AstraZeneca trial participant develops rare neurological condition following

• Natural News - Ethan Huff

(Natural News) It has come to our attention that a second participant in AstraZeneca's Wuhan coronavirus (COVID-19) vaccine trials has come down with a serious neurological condition that the company claims is not at all related to the volunteer getting vaccinated.

Just like the first participant, who we reported developed severe spinal inflammation, this second one also manifested the exact same disease, which AstraZeneca claims is "rare" and unrelated to its clinical trials.

After facing a barrage of criticism for its failure to disclose the details of its ongoing human trials, AstraZeneca reluctantly released data suggesting that transverse myelitis is a potential negative outcome of getting vaccinated for the Wuhan coronavirus (COVID-19).

The company's trials, which are being conducted in conjunction with the University of Oxford, were quickly resumed after the first victim was deemed to have had an undiagnosed case of multiple sclerosis. Now, AstraZeneca will have to come up with another excuse for this second victim.


thelibertyadvisor.com/declare